ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)

Volume 17, 9 Issues, 2017

Download PDF Flyer

Current Cancer Drug Targets

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 68th of 213 in Oncology

Submit Abstracts Online Submit Manuscripts Online

Ruiwen Zhang
Texas Tech University Health Sciences Center
1300 Coulter Drive
Amarillo, TX 79106

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.707
5 - Year: 3.446

Upcoming Articles (E-Pub Abstracts ahead of Print)

Histone Deacetylase Inhibitors for the Treatment of Colorectal Cancer: Recent Progress and Future Prospects

Avineesh Singh, Preeti Patel, Vijay Patel, Deepak K Jain, Ravichandran Veerasamy, Prabodh Chandere Sharma and Harish Rajak.

View Abstract

CD20-based Immunotherapy of B-cell Derived Hematologic Malignancies

Dariush Shanehbandi, Jafar Majidi, Tohid Kazemi, Behzad Baradaran and Leili Aghebati-Maleki.

View Abstract

Recent Advances in Application of Poly-epsilon-Caprolactone and its Derivative Copolymers for Controlled Release of Anti-tumor Drugs

Zhiqiang Sun, Ranglong Duan, Dejun Xing, Xuan Pang, Zhiying Li and Xuesi Chen.

View Abstract

The linkage between inflammation and immune tolerance: interfering with inflammation in cancer

Vladimir Stanislavovich Rogovskii.

View Abstract

Cathepsin D as a promising target for the discovery of novel anticancer agents

Vijaya Dubey and Suaib Luqman.

View Abstract

Studies on non-synonymous polymorphisms altering human DNA Topoisomerase II-alpha interaction with Amsacrine and Mitoxantrone: An in silico approach

Farzaneh Mohamadi Farsani, Mohamad Reza Ganjalikhany and Sadeq Vallian.

View Abstract

Orphan Drugs and Rare Diseases Europe 2017

Related Journals

Related eBooks

Webmaster Contact: Copyright © 2016 Bentham Science